Distribution and Cellular Localization of Prostacyclin Synthase in Human BrainIsabel Sieglea, Thomas Kleina, Ming-Hui Zoua, Peter Fritza, and Martin Kömhoffaa Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany Correspondence to: Isabel Siegle, Auerbachstr. 112, 70376 Stuttgart, Germany. E-mail: isabel.siegle@ikp-stuttgart.de
Prostacyclin (PGI2) is a labile, lipid-derived metabolite of arachidonic acid synthesized through the sequential action of cyclo-oxygenase (COX) and prostacyclin synthase (PGIS). In addition to its well-characterized vasodilatory and thrombolytic effects, an increasing number of studies report an important role of PGI2 in nociception in various animal species. In this study we investigated the regional distribution of PGIS in human brain by immunohistochemistry and in situ hybridization. PGIS-immunoreactive (ir) protein was localized to blood vessels throughout the brain. Neuronal cells and glial cells, such as microglia and oligodendrocytes, also showed intense labeling. The strongest expression of PGIS was seen in large principal neurons, such as pyramidal cells of the cortex, pyramidal cells of the hippocampus, and Purkinje cells of the cerebellum. Abundance of PGIS mRNA was observed in blood vessels and large neurons and correlated well with the immunohistochemical findings. The expression of PGIS in human brain was further demonstrated by immunoblotting and detection of 6-keto-PGF 1 Key Words: prostacyclin synthase, central nervous system, nociception, in situ hybridization, immunohistochemistry
This article has been cited by other articles:
|
|
||||||||||||||||||||||||||||||||||||||